Quantum-KI-Sturm:
Die größte Bedrohung für Hightech – Milliarden-Chance für Anleger!
Anzeige
REWALK ROBOTICS WKN: A12BMB ISIN: IL0011331076 Kürzel: 2RW Forum: Aktien Thema: Hauptdiskussion
2,10 USD
+1,94 %+0,04
28. Nov, 02:00:00 Uhr,
Nasdaq
Kommentare 2.189
S
Sulzbacher,
27.02.2024 16:45 Uhr
1
Leider bewegt sich der Kurs nicht... aber fällt zumindest nicht
S
Sulzbacher,
27.02.2024 15:12 Uhr
1
Fourth Quarter 2023 Financial Results
Total revenue was $6.9 million in the fourth quarter of 2023, compared to $2.2 million during the fourth quarter of 2022, up $4.7 million, or 216%. Revenue from the sale of products from the former ReWalk business was $2.2 million, flat with the prior year’s quarter. This performance was driven by flat revenue from the sale of ReWalk Exoskeleton systems and a small decline in MyoCycle revenue, offset by comparatively strong sales of ReStore systems. Revenue from the sale of products from the former AlterG business, which was acquired in August 2023, contributed $4.7 million.
Gross margin was 35.5% during the fourth quarter of 2023, compared to 30.9% in the fourth quarter of 2022. On a non-GAAP basis, which excludes the amortization of purchase accounting adjustments and inventory reserves listed in the attached non-GAAP reconciliation table, the adjusted gross margin was 47.0% in Q4’23, compared to 52.8% in Q4’22, a 5.8 percentage point decline. The decline in non-GAAP gross margin was primarily attributable to a more favorable mix of product sales and favorable material costs as a percentage of revenue in the prior year’s quarter.
Total operating expenses in the fourth quarter of 2023 were $8.6 million, compared to $5.7 million in the fourth quarter of 2022. Of the total, AlterG contributed $3.2 million of operating expenses in the fourth quarter of 2023. Excluding the impact of AlterG, operating expenses were $5.4 million in the fourth quarter of 2023, compared to $5.7 million in the fourth quarter of 2023, down $0.3 million, or -4%. Total operating expenses for the fourth quarter of 2023 included $1.6 million of expenses related to the acquisition of AlterG, including amortization of purchase accounting adjustments, restructuring, integration, and rebranding expenses, which are summarized in the attached non-GAAP reconciliation table.
Operating loss in the fourth quarter of 2023 was $6.1 million, compared to $5.0 million in the fourth quarter of 2022. On a non-GAAP basis, which excludes the items in the attached non-GAAP reconciliation table, adjusted operating loss was $3.8 million in the fourth quarter of 2023, compared to a loss of $4.0 million in the fourth quarter of 2022, an improvement of $0.2 million, or 6%.
Net loss was $5.6 million, or $(0.13) per share, for the fourth quarter of 2023, compared to a net loss of $5.3 million, or $(0.09) per share, in the fourth quarter of 2022. On a non-GAAP basis, which excludes the items in the attached non-GAAP reconciliation table, adjusted net loss was $3.3 million, or $(0.05) per share, in the fourth quarter of 2023, compared to $4.3 million, or $(0.07) per share, during the fourth quarter of 2022.
S
Sulzbacher,
27.02.2024 8:50 Uhr
0
Mit call
S
Sulzbacher,
27.02.2024 8:40 Uhr
0
Ist 14.30 bei uns...wenn ich richtig recherchiert habe😉
C
Christoph2000,
27.02.2024 7:56 Uhr
0
Zahlen müssten gleich durch sein 8.30 EST
S
Sulzbacher,
26.02.2024 8:02 Uhr
0
Auf eine spannende Woche😁
S
Sulzbacher,
16.02.2024 17:00 Uhr
0
Warte noch bis zu den Zahlen... dann wird entschieden
S
Sulzbacher,
31.01.2024 19:49 Uhr
0
Kommt keine Bewegung rein....
DaddyTrader,
30.01.2024 0:19 Uhr
0
https://golifeward.com 👍 Ich werde mal zeitnah einen neuen Blogeintrag machen um die neusten Entwicklungen zu beurteilen.
S
Sulzbacher,
29.01.2024 22:59 Uhr
0
Neuer Name.. neues Glück
S
Sulzbacher,
19.01.2024 16:41 Uhr
0
Schade ist der dampf raus.... sehen uns bald beim alten Kurs Niveau wieder wenn nicht news kommen...
S
Sulzbacher,
14.01.2024 19:37 Uhr
0
With the formation of our larger, newly combined commercial team, we have expanded three sales territories to include the major population centers in Canada,” said Larry Jasinski, Chief Executive Officer of ReWalk. “We believe that the Canadian market for Anti-Gravity systems has been underserved in the past, and we anticipate that our expanded direct sales presence will allow the Company to penetrate these markets more effectively.”
“The integration of AlterG and ReWalk continues to make great progress,” continued Mr. Jasinski. “In addition to the restructuring of our commercial teams, each of our functional areas has been realigned into our new operating structure. We believe that this integration will result in faster growth and a leaner cost structure, in line with our objectives to achieve profitability funded solely through our existing cash resources.”
Meistdiskutiert
|
Thema | ||
---|---|---|---|
1 | ATOS Hauptdiskussion | -44,74 % | |
2 | NVIDIA Hauptdiskussion | +1,47 % | |
3 | Europlasma Hauptdiskussion | -66,12 % | |
4 | Tonner Drones startet nach Vertrag mit Ukraine | -17,51 % | |
5 | GAMESTOP Hauptdiskussion | +1,21 % | |
6 | Spineway Act Hauptdiskussion | -43,28 % | |
7 | für alle, die es ehrlich meinen beim Traden. | ||
8 | VARTA Hauptdiskussion | +2,77 % | |
9 | die Story geht weiter! | -22,22 % | |
10 | Trading- und Aktien-Chat | Alle Diskussionen |
Aktien
|
Thema | ||
---|---|---|---|
1 | ATOS Hauptdiskussion | -40,29 % | |
2 | NVIDIA Hauptdiskussion | +1,47 % | |
3 | Europlasma Hauptdiskussion | -69,81 % | |
4 | Tonner Drones startet nach Vertrag mit Ukraine | -17,51 % | |
5 | GAMESTOP Hauptdiskussion | +1,21 % | |
6 | Spineway Act Hauptdiskussion | -43,28 % | |
7 | VARTA Hauptdiskussion | -0,63 % | |
8 | die Story geht weiter! | -22,22 % | |
9 | Vivoryon Therapeutics | +0,15 % | |
10 | BED BATH & BEYOND Hauptdiskussion | ±0,00 % | Alle Diskussionen |